These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25204194)

  • 61. [Academic discussion of adverse reaction of clinical trials of new traditional Chinese medicines and relevant influencing factors].
    Wang WP; Yu M; Wang L; Jiang XR; Li XB; Wang HW; Cao Y; Liu K; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(2):346-50. PubMed ID: 26080571
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Adverse drug reactions case reports for parenterally administered shuxuening based on analysis of literature].
    Ai QH; Wei X; Xie YM; Liao X; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3190-4. PubMed ID: 24471350
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety surveillance of traditional Chinese medicine: current and future.
    Liu SH; Chuang WC; Lam W; Jiang Z; Cheng YC
    Drug Saf; 2015 Feb; 38(2):117-28. PubMed ID: 25647717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Spontaneous reporting system data analysis of parenterally administered Shenmai].
    Wang LX; Xiang YY; Xie YM; Shen H; Ai QH
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2987-93. PubMed ID: 24471317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [To strengthen the monitoring and research on clinical adverse drug reaction induced by Chinese medicines].
    Chen K
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1091. PubMed ID: 11766603
    [No Abstract]   [Full Text] [Related]  

  • 66. [Using barcode in safety monitoring of traditional Chinese medicines injection].
    Wang ZF; Zhang DZ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2705-6. PubMed ID: 23285914
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Development of quality traceability system of traditional Chinese medicine].
    Cai Y; Hu H; Ni JY; Wang YT
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3829-33. PubMed ID: 24558859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations.
    Wang C; Shi QP; Ding F; Jiang XD; Tang W; Yu ML; Cheng JQ
    Biomed Pharmacother; 2019 Jan; 109():1523-1531. PubMed ID: 30551404
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Traditional Chinese medicine injection clinical use management model for evaluation].
    Liu F; Ma R; Liao X; Chai SW
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2752-5. PubMed ID: 23285927
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Causes and countermeasures about adverse reaction of traditional Chinese medicine].
    Wang Q; Li H; Zhang Z
    Zhong Yao Cai; 2001 Jun; 24(6):430-3. PubMed ID: 11563192
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipopolysaccharide aggravating anaphylactoid reactions caused by traditional Chinese Medicine injections via p38/ERK/NF-κB signaling pathways.
    Tang S; Qiu Z; Liu F; Li C; Peng G
    J Ethnopharmacol; 2025 Jan; 337(Pt 3):118946. PubMed ID: 39419299
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Safety research in Chinese medicines based on application of data mining].
    Tong Y; Yang J; Li C; He W
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Study on adverse drug reaction in Yuixngcao injection literatures].
    Wang Z; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2862-5. PubMed ID: 22292386
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Systematic analysis on clinical safety of Shuxuetong injection].
    Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A strategy for the detection of quality fluctuation of a Chinese herbal injection based on chemical fingerprinting combined with biological fingerprinting.
    Ren Y; Zhang P; Yan D; Wang J; Du X; Xiao X
    J Pharm Biomed Anal; 2011 Sep; 56(2):436-42. PubMed ID: 21664785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Specificity of traditional Chinese medicine's clinical re-evaluation].
    Li LD; Li YK; Li FJ
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):3-4. PubMed ID: 24754158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Meta-analysis on incidence of adverse drug reaction induced by Shuanghuanglian injection].
    Tang W; Shi QP; Ma T; Jiang XD; Liu SX; Wang YX
    Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2732-2742. PubMed ID: 28905614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Designing a Surveillance System in Canada to Detect Adverse Interactions Between Traditional Chinese Medicine and Western Medicine: Issues and Considerations.
    Zhang J; Ho K
    Stud Health Technol Inform; 2017; 234():412-417. PubMed ID: 28186077
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Influence factors for hepatotoxicity of traditional Chinese medicine preparations].
    Liu Y; Wang G; Zhong QX; Wu H; Song J; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3049-3055. PubMed ID: 29171220
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Influence factors of hepatotoxicity of traditional Chinese medicine preparation products based on multidimensional structure dynamic process].
    Liu Y; Wang G; Zhong QX; Wu H; Song J; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3031-3035. PubMed ID: 29171217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.